# Fidelity Emerging Markets Equity Research Enhanced UCITS ETF (FEMS) **Page:** https://fundology.uk/fund/fems · ISIN IE00BLRPN388 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, FEMS (Fidelity Emerging Markets Equity Research Enhanced UCITS ETF, ISIN IE00BLRPN388) closed at £5.20 on the London Stock Exchange. Its ongoing charge is 0.50% a year (about £50 on £10,000). Over the five years to 13/11/2026 its total return was +44.4%, or +12.7% after UK CPIH inflation. ## Summary Fidelity Emerging Markets Equity Research Enhanced UCITS ETF is an exchange-traded fund (ETF) from Fidelity, launched in 2020. It tracks the No Underlying Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.5% a year — about £50 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£5.20** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | FEMS | | ISIN | IE00BLRPN388 | | Also listed as | FEMR (London Stock Exchange, US dollars), FYER (Xetra, euros) | | Category | Emerging markets | | Type | ETF | | Provider | Fidelity | | Income | Accumulating | | Ongoing charge | 0.50% a year (£50 per £10,000) | | Fund size | £3.0bn | | Launched | 2020 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 24/11/2020 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +12.91% | +8.91% | income reinvested | | 3 years | +60.44% | +44.95% | income reinvested | | 5 years | +44.42% | +12.73% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF in pounds (price, with income reinvested in the fund): 2022 −12.4%, 2023 +3.0%, 2024 +7.7%, 2025 +26.0%; 2026 to 13/11/2026 +11.8%. Returns of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +28.4%; to 30/09/2025: +16.4%; to 30/09/2024: +13.7%; to 30/09/2023: +1.4%; to 30/09/2022: −13.9%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | -12.4% | -19.8% | Price | | 2023 | +3.0% | -1.1% | Price | | 2024 | +7.7% | +4.0% | Price | | 2025 | +26.0% | +21.7% | Price | | 2026 to 13/11/2026 | +11.8% | +8.2% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 20.91% | -13.79% | | 3 years | 16.56% | -13.79% | | 5 years | 16.61% | -24.26% | ## Largest fall Volatility of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 20.9% over 1 year, 16.6% over 3 years, 16.6% over 5 years. Largest fall in the price of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF since November 2021, in pounds: −22.6% from 19/11/2021 to 28/10/2022. The lowest 12-month return of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF in pounds (price, with income reinvested in the fund) since January 2021 was −21.1% (12 months to 28/10/2022); the highest was +57.6% (12 months to 19/06/2026). On 13/11/2026 the price of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF was 12.1% below its highest weekly close since November 2021 (19/06/2026), in pounds. ## Charges compared with similar funds Ongoing charge of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF 0.50% a year. Compared on 14/11/2026, 47 of the 151 other emerging-market share funds charge more, 12 the same and 92 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.50%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## Questions people ask **What is the ongoing charge of FEMS?** The ongoing charge of FEMS is 0.50% a year — about £50 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Fidelity Emerging Markets Equity Research Enhanced UCITS ETF 0.50% a year. Compared on 14/11/2026, 47 of the 151 other emerging-market share funds charge more, 12 the same and 92 less (share classes counted once). **Is FEMS accumulating or distributing?** FEMS is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of FEMS?** The ISIN of FEMS is IE00BLRPN388. An ISIN identifies one exact share class of a fund; FEMS is its ticker on the London Stock Exchange. The same share class is also listed as FEMR (London Stock Exchange, US dollars) and FYER (Xetra, euros). **What were FEMS’s returns in each of the last five years?** Calendar-year returns of FEMS in pounds (price, with income reinvested in the fund): 2022 −12.4%, 2023 +3.0%, 2024 +7.7%, 2025 +26.0%; 2026 to 13/11/2026 +11.8%. Past performance is not a guide to future returns. **How has FEMS done after inflation?** Over the five years to 13/11/2026 FEMS’s total return was +44.4%, or +12.7% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.